DECISION-MAKING AND PROBLEM SOLVING IN COMPLEX PCI: INTERACTIVE CASE-BASED LEARNING (I)

Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational... Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis. Read more Show less

Dr Justin Davies is a honorary 
interventional cardiologist at Hammersmith Hospital, Imperial... Dr Justin Davies is a honorary 
interventional cardiologist at Hammersmith Hospital, Imperial College NHS Trust, London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to
work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease. The holder of several patents,
he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies). Read more Show less

Prof Javier Escaned is Head of Section (Interventional Cardiology Section) at Hospital Clinico... Prof Javier Escaned is Head of Section (Interventional Cardiology Section) at Hospital Clinico San Carlos / Complutense University (Madrid, Spain). He trained in the United Kingdom as Specialist in Cardiology and obtained his PhD in The Netherlands. Author of >600 indexed scientific articles on interventional cardiology, imaging and physiology (h-index 90) and over 30 years of experience as PCI operator, he regularly lectures and performs live cases at major scientific and educational meetings. He is a recipient of the European Society of Cardiology (ESC) Silver Medal and the Andreas Grüntzig Award for his contributions to the fiedl fo Interventional Cardiology. Main areas of expertise include complex PCI, intracoronary diagnostics and functional coronary angiography. His track record in coronary physiology comprises being investigator on pioneer FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR, and developer of new tools for the assessment of coronary microcirculation. Editorial roles include Deputy Editor EHJ, Advisory Editor Eurointervention, editor of the textbooks “Coronary Stenosis: Imaging, Structure and Physiology” and “Physiological Assessment of Coronary Stenoses and the Microcirculation". Recent board positions include EAPCI board / Education Committee Chair, ESC WG Coronary Pathophysiology and Microcirculation, EuroCTO Board. Recent trials as Principal Investigator include ADVISE II, DEFINE FLAIR, SYNTAX II, PIONEER IV, Cerebral-Coronary-Connection (C3), DCR4Contrast, INOCA LongCovid and AID ANGIO. Additional interests are philosophy and music. Read more Show less

Dr Roberto Garbo is the Director of the CTO PCI, CHIP, and complex PCI program in Maria Pia... Dr Roberto Garbo is the Director of the CTO PCI, CHIP, and complex PCI program in Maria Pia Hospital GVM Care & Research, Turin, Italy. He was Head of the Cath Lab at San Giovanni Bosco Hospital from 2005-2020. He is the Director of the International Turin CTO & CHIP Live Congress. He has been Board member of EuroCTO Club from 2017 to 2023. Dr Garbo is one of the greatest experts in the world in the field of IVUS guided CTO in both antegrade and retrograde approach, with more than 2400 CTO of which more than 1100 retrograde CTO PCI. He performed as Live first operator more than 100 CTO PCI live cases during international CTO Congress . He is a Proctor for CTO PCI programs in Italy, Europe (France, Spain, Portugal, Poland, Romania, Czech republic, Russia) and Middle East (Egypt, Saudi Arabia), as well as an expert and proctor for Rotational Atherectomy in very calcified lesion (more than 1000 cases as first operator). He is also involved in many scientific projects with more than 130 papers in the field of CTO and Complex PCI. Read more Show less

Dr Asad Shabbir is an Interventional Cardiology Registrar at the John Radcliffe Hospital, Oxford... Dr Asad Shabbir is an Interventional Cardiology Registrar at the John Radcliffe Hospital, Oxford and is also an Honorary Clinical Research Fellow at the William Harvey Research Institute, Queen Mary University of London, where he is completing his PhD. He completed his interventional cardiology fellowship at Hospital Clinico San Carlos, Madrid, Spain. Asad has an interest in complex coronary interventions, CTO PCI, and translational basic science. Read more Show less

Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The... Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial. Read more Show less